ArticleEuropean journal of nuclear medicine and molecular imaging2021
[
Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?Contrast media & molecular imaging · 2022Pooled it
- State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2021Pooled it
- Evaluation of locoregional invasiveness of early lung adenocarcinoma manifesting as ground-glass nodules via [European journal of nuclear medicine and molecular imaging · 2025Trial
- PET imaging of mycobacterial infection: transforming the pipeline for tuberculosis drug development.Npj imaging · 2025Review
- Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Comparison of Al[Frontiers in oncology · 2025Article
- [European journal of nuclear medicine and molecular imaging · 2024Article
- Epithelioid granuloma mimicking lung cancer showed intense uptake on [European journal of nuclear medicine and molecular imaging · 2024Article
- Article
- Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects.Annals of nuclear medicine · 2024Review
- FAPI PET/CT Imaging-An Updated Review.Diagnostics (Basel, Switzerland) · 2023Review
- Benign lesions withThe British journal of radiology · 2023Article
- Non-oncologic incidental uptake on FAPI PET/CT imaging.The British journal of radiology · 2023Review
- Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.European journal of nuclear medicine and molecular imaging · 2022Review
- Article
- The potential utility of [European journal of nuclear medicine and molecular imaging · 2022Article
- HighEuropean journal of nuclear medicine and molecular imaging · 2022Article
- Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [European journal of nuclear medicine and molecular imaging · 2021Article
- Value of [European journal of nuclear medicine and molecular imaging · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32643006What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.